WallStSmart
PLRZ

Polyrizon Ltd. Ordinary Shares

NASDAQ: PLRZ · HEALTHCARE · BIOTECHNOLOGY

$16.12
-4.90% today

Updated 2026-06-04

Market cap
$27.97M
P/E ratio
P/S ratio
EPS (TTM)
$-4.90
Dividend yield
52W range
$3 – $18
Volume
0.0M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
27.6
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →205 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Altman Z 27.62 — safe zone
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-2.71M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00
Net income$-779000.00$-600000.00$-1.54M$-3.33M$-3.16M
EPS$-4.90
Free cash flow$-1.14M$-537000.00$-1.15M$-4.54M$-2.71M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PLRZ$27.97M234.33.05.07.3Avoid
LLY$1.08T7810.010.05.06.0Strong Buy
JNJ$613.02B574.79.03.36.0-87.08%Buy
ABBV$447.62B634.08.04.75.0-73.27%Buy
UNH$388.59B545.35.54.05.5-33.19%Buy
NVS$296.54B493.39.03.34.5-69.70%Hold

Smart narrative

Polyrizon Ltd. Ordinary Shares trades at $16.12. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 27.62, it sits in the safe zone.

Frequently asked questions

What is Polyrizon Ltd. Ordinary Shares's stock price?

Polyrizon Ltd. Ordinary Shares (PLRZ) trades at $16.12.

Is Polyrizon Ltd. Ordinary Shares overvalued?

Polyrizon Ltd. Ordinary Shares carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Polyrizon Ltd. Ordinary Shares's Altman Z-Score is 27.62, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-19.60%
Beta
50D MA$13.79
200D MA$10.82
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years